1. ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal
    Tao Zhou et al, 2022, Frontiers in Oncology CrossRef
  2. Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations
    Aussara Panya et al, 2023, Biomedicine & Pharmacotherapy CrossRef